Additionally, each autoantibody was associated with unique clinical characteristics, with anti‐CD209 IgM being more common in patients with CAD, anti‐CD209L IgM present exclusively in males, and anti‐ACE2 IgM and anti‐IFNα IgG associated with more severe disease. The gene discussed is ACE2; the disease is coronary artery disorder.